We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA’s Proposed Blister Packs for IR Opioids Draws Tepid Response
FDA’s Proposed Blister Packs for IR Opioids Draws Tepid Response
Drugmakers, trade groups and medical professionals have reservations about the FDA’s proposed blister pack requirements for certain immediate-release opioids, public comments show.